Symbiotec Pharmalab IPO is scheduled to list on 01 Sept 2026 on NSE, BSE.
Listed
Mainboard IPO
SYMBIOTEC
Symbiotec Pharmalab IPO Listing Price Today
Symbiotec Pharmalab IPO listed on 01 Sept 2026 at ₹988 against an issue price of ₹988, a listing gain of +0.00%.
- Issue price
- ₹988
- Actual listing price
- ₹988
- Listing Date
- 01 Sept 2026
- Exchange
- NSE, BSE
Live share price
Symbiotec Pharmalab share price
-
vs issue price
Open-
Day high-
Day low-
Exchange-
Loading live price…
The live price isn't available right now. Check back shortly.
Source: Yahoo Finance. Prices may be delayed by a few minutes.
GMP vs actual
Symbiotec Pharmalab listing price vs GMP estimate
| Issue price | ₹988 |
|---|---|
| Latest GMP | ₹185 (+18.72%) |
| Expected listing price (issue price + GMP) | ₹1,173 |
| Actual listing price | ₹988 |
| Listing gain | +0.00% |
| Difference from GMP estimate | -₹185 (-15.77%) |
Profit per application
₹0
At the listing price, for 15 shares
GMP is an unofficial grey market indicator, not a guarantee of the listing price.
Empirical GMP Accuracy:
Across 117 Indian IPOs, positive GMP predicted positive listing gains 69.8% of the time (72.2% of Mainboard IPOs opened within 10% of their GMP estimate).
View Research Report →
GMP trend
Symbiotec Pharmalab GMP trend before listing
| Date | GMP | Change |
|---|---|---|
| 01 Sept 2026 | ₹185.00 | -75 |
| 31 Aug 2026 | ₹260.00 | -15 |
| 28 Aug 2026 | ₹275.00 | -10 |
| 27 Aug 2026 | ₹285.00 | -67 |
| 26 Aug 2026 | ₹352.00 | +12 |
| 25 Aug 2026 | ₹340.00 | -69 |
| 24 Aug 2026 | ₹409.00 | +64 |
Listing day
Listing day timings
| Listing Date | 01 Sept 2026 |
|---|---|
| Special pre-open session | 9:00 AM - 9:45 AM |
| Normal trading starts | 10:00 AM |
| Exchange | NSE, BSE |
FAQ
Symbiotec Pharmalab IPO: frequently asked questions
Symbiotec Pharmalab IPO listed at ₹988 against an issue price of ₹988, a listing gain of +0.00%.
On listing day, a special pre-open session runs from 9:00 AM to 9:45 AM to set the listing price. Symbiotec Pharmalab shares then start normal trading at 10:00 AM.
In our empirical study of 117 Indian IPO listings, positive GMP was followed by a positive listing gain 69.8% of the time. However, as an exact forecast, the median variation between GMP-implied gain and actual listing price was 8 percentage points. GMP reflects informal market sentiment and should always be evaluated alongside company valuation and fundamentals.
At the listing price, one minimum application of 15 shares in Symbiotec Pharmalab IPO made about ₹0.